MIR181D is a microRNA that has been associated with various biological processes and diseases. The rs8108402 C/T polymorphism, located in the promoter region of MIR181D, has been linked to susceptibility to systemic lupus erythematosus in the Chinese population of Guanxi Province [PMC9396029]. Ectopic expression of MIR181D has been shown to suppress tumor cell growth by downregulating MALT1 [PMC6125328]. However, relative quantification revealed no compensatory up-regulation of MIR181D in miR-181a/b-1 knockout thymocytes [PMC4682956]. MIR181D is involved in the regulation of sterol O-acyltransferase 2 (SOAT2), which plays a crucial role in cholesterol conversion [PMC7460638]. Additionally, MIR181D and other miRNAs have been shown to function as transcriptional regulators by binding to DNA promoters [PMC9967498]. In the context of chronic obstructive pulmonary disease (COPD), downregulation of MIR181D and other miRNAs has been observed in lung tissue, while increased expression of miR223 and miR424-5p has been associated with COPD-related muscle wasting [PMC6089098] [PMC6089098] [PMC6089098] . These findings suggest that microRNA-mRNA interactions may play important roles in COPD pathogenesis. Furthermore, next-generation sequencing and bioinformatic analyses have revealed interactions between NEAT1, various pseudogenes, miRNAs (including MIR181D), protein-coding genes, rRNAs, snRNAs, and tRNA within the microenvironment of COPD airways [PMC9730017]. In summary, MIR181D is a microRNA involved in various biological processes and diseases. Its polymorphism has been associated with susceptibility to systemic lupus erythematosus, and its ectopic expression has been shown to suppress tumor cell growth. MIR181D is also involved in the regulation of cholesterol conversion and functions as a transcriptional regulator. In the context of COPD, downregulation of MIR181D and other miRNAs has been observed in lung tissue, while increased expression of certain miRNAs has been associated with muscle wasting. The interactions between MIR181D and other molecules within the COPD airway microenvironment have also been identified.
-- - ----aca ga aucA GUUG g a gac gucccc uccccu aggcc gcc ggucaca ACAUUCAUU UCGGUGGGUu ug g u |||||| |||||| ||||| ||| ||||||| ||||||||| |||||||||| || | cagggg agggga uucgg cgg ucggugu UGUAAGUAG GGCCACCcag ac c g ua a cacagac -g -CAC --GG - - gga
Name | Accession | Chromosome | Start | End | Strand | Confidence |
---|
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0002821 |
Description | Homo sapiens hsa-miR-181d-5p mature miRNA |
Sequence | 36 - AACAUUCAUUGUUGUCGGUGGGU - 58 |
Evidence |
experimental
array-cloned [1], cloned [2], Illumina [3] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() |
Accession | MIMAT0026608 |
Description | Homo sapiens hsa-miR-181d-3p mature miRNA |
Sequence | 79 - CCACCGGGGGAUGAAUGUCAC - 99 |
Evidence |
experimental
Illumina [3] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() |
|